INTRODUCTION: The surgical issues of @entity8 ( @entity8 ) after @entity263 (PC) treatment and oncological outcomes after transplantation in @entity1 on the waiting list with a history of PC were unknown. We conducted a retrospective multicentre study including all @entity1 with PC diagnosed before the kidney transplantation. METHODS: Fifty-two @entity1 were included from December 1993 to December 2015. The median age at diagnosis of PC was 59.8years old. RESULTS: The median PSA rate at diagnosis was 7ng/mL. Twenty-seven, Twenty-four, and one PC were respectively low, intermediate and high risk according to d'Amico classification. Forty-three @entity1 were treated by radical prostatectomy (RP): 28 retropubic, 15 laparoscopic and 3 by a perineal approach. Eighteen @entity1 had a lymph node dissection. Four @entity1 were treated with external radiotherapy and 2 by brachytherapy. Eight @entity1 underwent radiotherapy after surgery. The median time between PC treatment and @entity8 was 35.7 months. The median operating time for the @entity8 was 180min (IQR 150-190; min 90-max 310) with a median intraoperative bleeding of 200mL (IQR 100-290; min 50-max 2000). A history of lymphadenectomy did not significantly lengthen operative time (P=0.34). No recurrence of PC was observed after a median follow of 36months. CONCLUSION: PC discovered before @entity8 should be treated with RP to assess the risk of recurrence and decrease waiting for a @entity8 . If the PC is at low risk of recurrence, it seems possible to shorten the waiting time before the @entity8 after a multidisciplinary discussion meeting. LEVEL OF EVIDENCE: 4.

XXXX before @entity8 : A multicentre study.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity8 :: ('MESH:D007674', 'Disease') :: ['RT', 'renal transplantation'] @entity263 :: ('MESH:D011471', 'Disease') :: ['localized prostate cancer']
@entity263 :: (MESH:D011471,Disease) :: ['Prostate cancer']
